As a heterogeneous disease, breast cancer can be classified into different molecular subtypes according to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status, which resulted in individualized treatment (2). This evidence concerns the gene ESR1 and breast cancer.